FDA officials say this is the first epinephrine product for anaphylaxis that is not administered with a needle.

The spray was distributed by Green Pharmaceuticals Inc., of Camarillo, Calif., and had been sold on the company’s website and ...

The FDA has approved a nasal spray, called neffy, to treat serious allergic reactions in adults and children who weigh at ...

The maker of a homeopathic nasal spray with a history of contamination is refusing to recall its product after the Food and ...

SoundHealth launched a new feature in its AI-powered health care app that will give users personalized allergy forecasts to ...

The FDA recently approved the first needle-free epinephrine product (neffy), an alternative to injectable epinephrine (EpiPen ...

The FDA announced earlier today that ilunocitinib tablets (Zenrelia; Elanco) has received its approval. The latest drug from ...

A nasal spray developed ... Research shows the spray, recently approved in the EU and US, is just as effective at stopping ...

ARS Pharmaceuticals' neffy, a needle-free nasal spray for allergies, receives FDA approval, driving stock price up 120%. Read ...

We came across a bullish thesis on ARS Pharmaceuticals (SPRY) on Value Degen’s Substack by Unemployed Value Degen. In this ...

The FDA has approved AstraZeneca's Fasenra for eosinophilic granulomatosis with polyangiitis based on Phase 3 MANDARA trial ...